Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8756684rdf:typepubmed:Citationlld:pubmed
pubmed-article:8756684lifeskim:mentionsumls-concept:C0006772lld:lifeskim
pubmed-article:8756684lifeskim:mentionsumls-concept:C2752415lld:lifeskim
pubmed-article:8756684lifeskim:mentionsumls-concept:C0040979lld:lifeskim
pubmed-article:8756684lifeskim:mentionsumls-concept:C1420704lld:lifeskim
pubmed-article:8756684lifeskim:mentionsumls-concept:C1419423lld:lifeskim
pubmed-article:8756684lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:8756684lifeskim:mentionsumls-concept:C0037633lld:lifeskim
pubmed-article:8756684lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:8756684lifeskim:mentionsumls-concept:C1382100lld:lifeskim
pubmed-article:8756684lifeskim:mentionsumls-concept:C0205431lld:lifeskim
pubmed-article:8756684pubmed:issue32lld:pubmed
pubmed-article:8756684pubmed:dateCreated1996-9-30lld:pubmed
pubmed-article:8756684pubmed:abstractTextThe binding of the antagonists N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide (J-8) and trifluoperazine (TFP) to intact calcium-saturated bovine calmodulin (CaM) and also of J-8 to the C-terminal domain (tr2c) has been investigated. Using a combination of NMR methods, including NOESY data, mobility measurements, and chemical shift and line-shape analysis, we show that the primary interaction between J-8 and tr2c is between the naphthalene ring of the antagonist and the hydrophobic pocket of the protein, similar to the binding of the hydrophobic side-chain residues of calmodulin target peptides. Comparison of the mobility of the drug, the intensity and pattern of intermolecular NOESY cross-peaks, and chemical shift changes shows that there is no significant change in the binding mode in J-8. CaM compared to J-8.tr2c, with one molecule binding to each domain. In particular, we find that the mobility of the aliphatic amino "tail" of J-8 remains highly mobile in both systems. This contrasts with the notion that the tail may bridge between the two domains to give a "globular" form of CaM. We also show that TFP induces very similar shift changes to J-8 and that the stoichiometry of the major binding event in all three cases is one drug molecule per domain. It also appears that secondary binding sites for the drug molecules are present in all three systems.lld:pubmed
pubmed-article:8756684pubmed:languageenglld:pubmed
pubmed-article:8756684pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8756684pubmed:citationSubsetIMlld:pubmed
pubmed-article:8756684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8756684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8756684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8756684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8756684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8756684pubmed:statusMEDLINElld:pubmed
pubmed-article:8756684pubmed:monthAuglld:pubmed
pubmed-article:8756684pubmed:issn0006-2960lld:pubmed
pubmed-article:8756684pubmed:authorpubmed-author:ThulinEElld:pubmed
pubmed-article:8756684pubmed:authorpubmed-author:JonesS KSKlld:pubmed
pubmed-article:8756684pubmed:authorpubmed-author:BlackburnG...lld:pubmed
pubmed-article:8756684pubmed:authorpubmed-author:WalthoJ PJPlld:pubmed
pubmed-article:8756684pubmed:authorpubmed-author:WhiteheadBBlld:pubmed
pubmed-article:8756684pubmed:authorpubmed-author:CravenC JCJlld:pubmed
pubmed-article:8756684pubmed:issnTypePrintlld:pubmed
pubmed-article:8756684pubmed:day13lld:pubmed
pubmed-article:8756684pubmed:volume35lld:pubmed
pubmed-article:8756684pubmed:ownerNLMlld:pubmed
pubmed-article:8756684pubmed:authorsCompleteYlld:pubmed
pubmed-article:8756684pubmed:pagination10287-99lld:pubmed
pubmed-article:8756684pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8756684pubmed:meshHeadingpubmed-meshheading:8756684-...lld:pubmed
pubmed-article:8756684pubmed:meshHeadingpubmed-meshheading:8756684-...lld:pubmed
pubmed-article:8756684pubmed:meshHeadingpubmed-meshheading:8756684-...lld:pubmed
pubmed-article:8756684pubmed:meshHeadingpubmed-meshheading:8756684-...lld:pubmed
pubmed-article:8756684pubmed:meshHeadingpubmed-meshheading:8756684-...lld:pubmed
pubmed-article:8756684pubmed:meshHeadingpubmed-meshheading:8756684-...lld:pubmed
pubmed-article:8756684pubmed:meshHeadingpubmed-meshheading:8756684-...lld:pubmed
pubmed-article:8756684pubmed:meshHeadingpubmed-meshheading:8756684-...lld:pubmed
pubmed-article:8756684pubmed:year1996lld:pubmed
pubmed-article:8756684pubmed:articleTitleComplexes formed between calmodulin and the antagonists J-8 and TFP in solution.lld:pubmed
pubmed-article:8756684pubmed:affiliationDepartment of Molecular Biology and Biotechnology, University of Sheffield, U.K.lld:pubmed
pubmed-article:8756684pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8756684pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8756684lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8756684lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8756684lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8756684lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8756684lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8756684lld:pubmed